Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.85+0.04 (+5.13%)
Close on Nov 18, 2026Market cap $109.79MP/E –Yield –
Organogenesis market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Organogenesis's market cap was $135.11M on Nov 11, 2026, against $657.40M a year earlier. Over the last 5 years it ranged from $98.83M to $1.19B, with a median of $424.24M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $135.11M | -79.4% |
| 2025 | Dec 31, 2025 | $657.40M | +55.0% |
| 2024 | Dec 31, 2024 | $424.24M | -21.0% |
| 2023 | Dec 29, 2023 | $537.07M | +52.5% |
| 2022 | Dec 30, 2022 | $352.16M | -70.4% |
| 2021 | Dec 31, 2021 | $1.19B | +46.9% |
| 2020 | Dec 31, 2020 | $809.15M | +77.6% |
| 2019 | Dec 31, 2019 | $455.71M | -32.1% |
| 2018 | Dec 31, 2018 | $670.66M | +32.6% |
| 2017 | Dec 29, 2017 | $505.72M | – |
See a number that looks wrong?